The Trend in Biosimilar Development and Recent FDA Guidance
Learn more about the recent trends in biosimilar development, the FDA guidance on biosimilars, and how clinical trial designs need to adapt accordingly
Learn more about the recent trends in biosimilar development, the FDA guidance on biosimilars, and how clinical trial designs need to adapt accordingly
In this video Quanticate explores the creation of two ADaM datasets; ADPC and ADPP for Pharmacokinetic (PK) Analysis in clinical trials
Quanticate's latest blog explores generating CDISC Compliant PK Workflows as part of Pharmacokinetic Analyses.
This recent blog by Quanticate examines Pharmacokinetic Considerations when comparing Biosimilarities
When using SAS Business Intelligence in Clinical Trials, this infographic explores the process of how data arrives into the Web Report Studio
Quanticate looks at SAS and WinNonlin as PK analysis tools. The pros and cons of either model in deciding how to handle your Pharmacokinetic data.